Májský A, Dvoráková M, Zvolský P
Folia Haematol Int Mag Klin Morphol Blutforsch. 1978;105(4):509-17.
In 54 (= 46.96%) of 115 patients with maniacal-depressive psychosis a HLA modification could be identified. This modification turned out to be temporary and from a serological point of view it revealed a different character. In 29 cases a loss of HLA antigens could be observed, in 3 cases there was a decrease, in 14 cases a combination of both changes, twice a polyreactivity was observed and 6 times a change of the antigen HLA-A 2 in A 28 could be determined. These serological modifications appeared after therapy with lithium as well as with various antidepressive and neuroleptic medicaments. The connection between therapy and development of HLA modification could be ensured statistically. The modifications of HLA antigens A 10 and B 7 developed after administering neuroleptic medicaments, those of HLA antigens A 9, A 11, B 12, and B 13 after therapy with antidepressive medicaments. HLA antigens B 27 and B 40 showed a relative resistance towards therapy. The significance of these findings for the possibility of mistakes in HLA typing and from the standpoint of therapy efficiency in connection with the patient's HLA phaenotype is discussed.
在115例躁狂抑郁症患者中,有54例(占46.96%)可发现HLA改变。这种改变被证明是暂时的,从血清学角度来看,它呈现出不同的特征。在29例中可观察到HLA抗原缺失,3例有减少,14例两种改变都有,2次观察到多反应性,6次可确定抗原HLA - A2变为A28。这些血清学改变在使用锂盐以及各种抗抑郁药和抗精神病药治疗后出现。治疗与HLA改变发生之间的关联可通过统计学方法确定。抗精神病药给药后出现HLA抗原A10和B7的改变,抗抑郁药治疗后出现HLA抗原A9、A11、B12和B13的改变。HLA抗原B27和B40对治疗表现出相对抗性。讨论了这些发现对于HLA分型错误可能性以及从与患者HLA表型相关的治疗效果角度的意义。